Trial Outcomes & Findings for Determination of the Glycemic Index and the Insulinemic Index of a Sweetener Syrup (NCT NCT00717912)

NCT ID: NCT00717912

Last Updated: 2017-07-13

Results Overview

The specific measure that will be use to determine the glycemic responses is the change in blood sugar levels compared with the levels achieved after they have eaten a control food containing the same amount of digestible carbohydrate. Sugar syrup was used as the reference food, giving it a glycemic index value of 100 by definition. The AUC of the test food is divided by the AUC of the standard (glucose) and multiplied by 100. Low GI: 55 or less, Medium GI: 56-69, High GI: 70 and above

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

6 participants

Primary outcome timeframe

Every 48 hours (each new intervention), over a 2 hour blood glucose challenge

Results posted on

2017-07-13

Participant Flow

Participant milestones

Participant milestones
Measure
Arm 1
Classical sugar syrup/ Classical sweetener syrup / Classical sugar syrup / Experimental sweetener syrup / Experimental sweetener syrup / Experimental sweetener syrup / Classical sugar syrup
Arm 2
Experimental sweetener syrup / Experimental sweetener syrup / Classical sugar syrup / Classical sugar syrup / Classical sweetener syrup / Classical sugar syrup / Experimental sweetener syrup
Arm 3
Experimental sweetener syrup / Classical sugar syrup / Experimental sweetener syrup / Classical sweetener syrup / Classical sugar syrup / Classical sugar syrup / Experimental sweetener syrup
Arm 4
Experimental sweetener syrup / Experimental sweetener syrup / Experimental sweetener syrup / Classical sugar syrup / Classical sugar syrup / Classical sugar syrup / Classical sweetener syrup
Arm 5
Classical sugar syrup / Experimental sweetener syrup / Classical sweetener syrup / Experimental sweetener syrup / Experimental sweetener syrup / Classical sugar syrup / Classical sugar syrup
Arm 6
Experimental sweetener syrup / Experimental sweetener syrup / Experimental sweetener syrup / Classical sugar syrup / Classical sweetener syrup / Classical sugar syrup / Classical sugar syrup
Overall Study
STARTED
1
1
1
1
1
1
Overall Study
COMPLETED
1
1
1
1
1
1
Overall Study
NOT COMPLETED
0
0
0
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Determination of the Glycemic Index and the Insulinemic Index of a Sweetener Syrup

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
All Participants
n=6 Participants
Each subject received the study products in different order according to the randomization list
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
6 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Age, Continuous
23.7 years
STANDARD_DEVIATION 4.9 • n=5 Participants
Sex: Female, Male
Female
0 Participants
n=5 Participants
Sex: Female, Male
Male
6 Participants
n=5 Participants
Region of Enrollment
France
6 participants
n=5 Participants

PRIMARY outcome

Timeframe: Every 48 hours (each new intervention), over a 2 hour blood glucose challenge

The specific measure that will be use to determine the glycemic responses is the change in blood sugar levels compared with the levels achieved after they have eaten a control food containing the same amount of digestible carbohydrate. Sugar syrup was used as the reference food, giving it a glycemic index value of 100 by definition. The AUC of the test food is divided by the AUC of the standard (glucose) and multiplied by 100. Low GI: 55 or less, Medium GI: 56-69, High GI: 70 and above

Outcome measures

Outcome measures
Measure
Classical Sugar Syrup
n=6 Participants
The subjects consumed three time this product
Experimental Sweetener Syrup
n=6 Participants
The subjects consumed three times this product
Classical Sweetener Syrup
n=6 Participants
The subjects consumed once this product
Glycemic Index
100 % of GI of the glucose
Standard Deviation 0
33.68 % of GI of the glucose
Standard Deviation 20.28
12.83 % of GI of the glucose
Standard Deviation 14.74

SECONDARY outcome

Timeframe: Every 48 hours (each new intervention), over a 2 hour blood glucose challenge

The specific measure that will be use to determine the insulinemic responses is the change in blood insuline levels compared with the levels achieved after they have eaten a control food containing the same amount of digestible carbohydrate. Sugar syrup was used as the reference food, giving it a insulinemic index value of 100 by definition. The AUC of the test food is divided by the AUC of the standard (glucose) and multiplied by 100. Low GI: 55 or less, Medium GI: 56-69, High GI: 70 and above

Outcome measures

Outcome measures
Measure
Classical Sugar Syrup
n=6 Participants
The subjects consumed three time this product
Experimental Sweetener Syrup
n=6 Participants
The subjects consumed three times this product
Classical Sweetener Syrup
n=6 Participants
The subjects consumed once this product
Insulinemic Index
100 % of the GI of the glucose
Standard Deviation 0
34.28 % of the GI of the glucose
Standard Deviation 16.57
17.38 % of the GI of the glucose
Standard Deviation 14.09

Adverse Events

Classical Sugar Syrup

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Experimental Sweetener Syrup

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

Classical Sweetener Syrup

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Classical Sugar Syrup
n=6 participants at risk
The subjects consumed three times this product
Experimental Sweetener Syrup
n=6 participants at risk
The subjects consumed three times this product
Classical Sweetener Syrup
n=6 participants at risk
The subjects consumed once this product
Gastrointestinal disorders
diarrhea
0.00%
0/6
50.0%
3/6 • Number of events 3
16.7%
1/6 • Number of events 1
General disorders
Headache
0.00%
0/6
16.7%
1/6 • Number of events 1
0.00%
0/6

Additional Information

Doctor

Biofortis

Phone: 0240205799

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: GT60